Esperion hits a homer with new cholesterol data

05:37 EDT 8 Aug 2017 | BioPharmaDive

Stock surged on news that patients taking a statin and a drug combination including its bempedoic acid had a 64% reduction in bad cholesterol levels.

Original Article: Esperion hits a homer with new cholesterol data


More From BioPortfolio on "Esperion hits a homer with new cholesterol data"

Quick Search

Relevant Topics

Cholesterol is a waxy steroid metabolite found in the cell membranes and transported in the blood plasma. It is an important structural component of mammalian cell membranes, where it is establishes proper membrane permeability and fluidity. Cholesterol ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Statins (or HMG-CoA reductase inhibitors) are a class of drug used to lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver. Increased cholesterol levels have been as...